当前位置: 首页 > 期刊 > 《中国保健》 > 2010年第2期
编号:11916078
新型烷化剂替莫唑胺治疗胶质母细胞瘤的研究(3)
http://www.100md.com 2010年1月15日 李学 王增光 杨卫东 杨学军 杨树源 张建宁 岳树源
第1页

    参见附件(2402KB,3页)。

     [2]Cavaliere R,Wen PY,Schiff D.Novel therapies for m alignant gliomas.Neurol Clin,2007,Nov,25(4): 1141.

    [3]杨树源,只达石. 神经外科学 [M]. 北京:人民卫生出版社,2007: 477.

    [4]Asthagiri AR, Pouratian N, Sherman J, et al. Advances in brain tumor surgery[J]. Neurol Clin, 2007, 25(4): 975.

    [5]Lukas RV, Boire A, Nicholas MK. Emerging therapies for m alignant glioma [J]. Expert Rev Anticancer Ther, 2007,7(12):29-36.

    [6]Brandes AA,Vastola F,Basso U,et a1. A prospective study on glioblastoma in the elderly [J]. Cancer,2003, 97(3):657.

    [7]Gliomas Meta-Analysis Group. Chemotherapy in adult high-grade glioma:a systematic review and meta-analysis of invidual patient data from 12 randomised trials. Lancet,2002,359(9311):1011.

    [8]Chfibbaro S,Benvenuti L,Caprio A,et a1. Temozolomide as first 1ine agent in treating high grade gliomas:phase II study [J].Neurooncol,2004,67(1): 77.

    [9]Chang SM,Theodosopoulos P,Lamborn K,et a1. Temozolomide in the treatment of recurrent m alignant glioma [J]. Cancer, 2004,3(100):605.

    [10] Balana C,Capellades J, Teixidor P, et a1.Clinical course of high-grade glioma patients with a “biopsy-only”surgical approach:a need for individualised treatment [J]. Clin Transl Oncol. 2007, 9(12):797.

您现在查看是摘要介绍页,详见PDF附件(2402KB,3页)